ORPH

Orphazyme A/S

Delisted

ORPH was delisted on the 30th of March, 2022.

16 hedge funds and large institutions have $35.9M invested in Orphazyme A/S in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
16
Holders Change
+16
Holders Change %
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
16
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
IM
1
Islet Management
New York
$14M 1,353,768 +1,353,768 New
Bank of America
2
Bank of America
North Carolina
$5.46M 528,991 +528,991 New
GCP
3
GSA Capital Partners
United Kingdom
$5.06M 490,000 +490,000 New
Citadel Advisors
4
Citadel Advisors
Florida
$2.07M 200,000 +200,000 New
CH
5
CVI Holdings
Delaware
$1.81M 175,000 +175,000 New
MIM
6
Monashee Investment Management
Massachusetts
$1.81M 175,000 +175,000 New
SSA
7
Schonfeld Strategic Advisors
New York
$1.54M 149,500 +149,500 New
MS
8
Maven Securities
Jersey
$1.3M 128,844 +128,844 New
HP
9
Hound Partners
New York
$1.03M 100,000 +100,000 New
MWNA
10
Marshall Wace North America
New York
$840K 81,332 +81,332 New
SIGI
11
Susquehanna International Group (Ireland)
Ireland
$510K 49,400 +49,400 New
CCM
12
CAAS Capital Management
New York
$258K 25,000 +25,000 New
AI
13
Atom Investors
Texas
$103K 10,000 +10,000 New
FIA
14
FNY Investment Advisers
New York
$96K 9,300 +9,300 New
PA
15
Parallel Advisors
California
$4K 400 +400 New
Millennium Management
16
Millennium Management
New York
$2.04K 197,556 +197,556 New
CFGS
17
Concourse Financial Group Securities
Alabama